Clinical Trial Update: Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Depakote monotherapy, olanzapine monotherapy, and their combination for maintenance bipolar disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)
• olanzapine (olanzapine)

Snippet

Sponsor: Abbott | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED